ASCO update —hepatocellular carcinoma and cholangiocellular carcinoma

SummaryTwo exciting phase 2 dates were presented at Asco. This results in a new phase III study for Hepatocelluar cancer that will be launched soon.
With Cholangiocarcinoma there is a new substance that shows very good oberall response rates in a subgroup of patients.

Source: Memo - Magazine of European Medical Oncology - October 27, 2023 Category: Cancer & Oncology Source Type: research